InvestorsHub Logo
Followers 241
Posts 4676
Boards Moderated 2
Alias Born 08/03/2006

Re: None

Wednesday, 10/28/2020 2:52:05 PM

Wednesday, October 28, 2020 2:52:05 PM

Post# of 90086
HUGE MARKET SELLOFF.. 2nd WAVE of COVID in FRANCE.. talking shutting it down... "Nationwide and International distribution as PARTNERS" (see below)

What a good time to be in the BIZZ of Fighting VIRUSES.... and CLEANING up after them... whether it be UV... or more traditional methods... James knows what he is doing and his CONNECTIONS are opening up all kinds of doors... big breakout coming soon! Real soon...



Poverty Dignified Signs LOI With Safer Place Technologies LLC
Poverty Dignified, Inc.
Mon, October 26, 2020, 9:00 AM EDT
Collaboration Anticipated to Accelerate Company’s Growth in Anti-Viral Sectors


KENNEWICK, WA, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Poverty Dignified, Inc. (OTC -PVDG) is pleased to announce today that the Company has executed a binding Letter of Intent (LOI) to acquire all intellectual property and proprietary technology represented by the trade name Safer Place Technologies LLC, a newly formed company created for the online marketing, sales and distribution of antimicrobial and antiviral products and services. (“Safer Place Market™”).

This collaboration is expected to accelerate the revenue growth of Poverty Dignified, Inc. in providing employers, workplaces, schools, churches, public transportation, restaurants, stadiums, and a multitude of additional private and public venues with quality products and new technologies to provide a healthier and safer environment.

James C. Katzaroff, CEO of Poverty Dignified, Inc., said, “Safer Place Technologies is currently a Wyoming LLC owned by a team of seasoned marketers and managers with vast experience in providing solutions for a variety of challenges facing society. We now have the means to better vet vendors for the Safer Place Market™ who show interest in nationwide and international distribution as partners for branding, marketing, manufacturing and advertising exposure of antimicrobial and antiviral products.”